Stephen V Liu: Great talks on immunotherapy and cell therapy at the 2023 Thomas Shea Clinical Cancer Symposium

Stephen V Liu shared a post on X:

“Some great talks on immunotherapy and cell therapy at the 2023 Thomas Shea Clinical Cancer Symposium, UNC Lineberger from Dr. Julie Brahmer and Dr. Jared Weiss. Excitement here for dual checkpoint blockade and cell therapy for select patients.”

Source: Stephen V Liu/X

Stephen V Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.

Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.